News
Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the ...
Stepping down to as-needed ICS/FABA maintained asthma stability while significantly reducing steroid exposure in individuals ...
An international team of researchers led by Professor Morris Brown FRS at Queen Mary University of London found that ...
Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results